HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of systemic diseases with pulse cyclophosphamide: 15 cases].

Abstract
Fifteen patients suffering from severe systemic diseases were treated with monthly pulses administration of cyclophosphamide (0.7 g/m2 of body surface): 8 acute systemic lupus erythematosus, 2 Wegener's granulomatous, 1 polyarteritis nodosa, 1 rheumatoid vasculitis, 1 progressive systemic sclerosis, 1 relapsing uveitis and 1 dermatopolymyositis. The indications for cyclophosphamide were: glomerulonephritis (6 cases), resistance to previous treatments (7 cases) and undesirable side effects of corticosteroid therapy (2 cases). After 3 pulses, the disease was controlled in 12 patients (80%) and corticosteroids could be decreased in all 12 cases without an evolutive relapse of the disease. Five patients developed infections (2 septicemia, 1 zona, 1 herpes gingival stomatitis and 1 viral meningitis) which were treated without sequelae. One patient developed cystitis with hematuria after the 3rd pulse; association of mesna, a urinary tract protective agent, enabled the continuation of treatment without a cystitis relapse. At the end of our retrospective study, the efficacy of pulse cyclophosphamide administration seems to be satisfactory but the risk of undesirable side effects should limit its use to severe systemic diseases or those resistant to conventional therapies.
AuthorsZ Amoura, G Choukroun, I Royer, M Gayraud, L Guillevin
JournalAnnales de medecine interne (Ann Med Interne (Paris)) Vol. 141 Issue 5 Pg. 416-20 ( 1990) ISSN: 0003-410X [Print] France
Vernacular TitleTraitement des maladies systémiques par bolus de cyclophosphamide. Quinze observations.
PMID2256584 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Cyclophosphamide
Topics
  • Adult
  • Collagen Diseases (drug therapy)
  • Connective Tissue Diseases (drug therapy)
  • Cyclophosphamide (administration & dosage, adverse effects, therapeutic use)
  • Female
  • Humans
  • Injections, Intravenous (methods)
  • Male
  • Middle Aged
  • Pulsatile Flow
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: